IL1A and colitis: Our findings that L-Arg also effectively reduced other proinflammatory mediators, such as the innate immune cell products IL-1α, IL-1β, and IL-6, as well as the prototype Th17 cytokine, IL-17, suggest that it may be broadly beneficial in colitis.